Suchergebnisse - "Kahan, Thomas"

PubPharm (25)

1

Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment : results from the SILVHIA study

enthalten in: Journal of cardiovascular pharmacology | 2013

von Jekell, A. | Malmqvist, K. | Wallén, N. | +2

2

Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate : an analysis of the ASSOCIATE study

enthalten in: International journal of cardiology | 2013

von Tardif, J. | Ponikowski, P. | Kahan, T. | +1

3

The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy : results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA)

enthalten in: Echocardiography (Mount Kisco, N.Y.) | 2009

von Liljedahl, S. | Kahan, T. | Lind, L. | +1

4

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy : a 4-month, randomized, placebo-controlled trial

enthalten in: European heart journal | 2009

von Tardif, J. | Ponikowski, P. | Kahan, T. | +101

CommentIn: Eur Heart J. 2009 Mar;30(5):524-5. - PMID 19193673

5

The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

enthalten in: PharmacoEconomics | 2009

von Lindgren, P. | Buxton, M. | Kahan, T. | +5

6

The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

enthalten in: PharmacoEconomics | 2009

von Lindgren, P. | Buxton, M. | Kahan, T. | +5

7

The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

enthalten in: PharmacoEconomics | 2009

von Lindgren, P. | Buxton, M. | Kahan, T. | +5

8

The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone : results from ASCOT1

enthalten in: PharmacoEconomics | 2009

von Lindgren, P. | Buxton, M. | Kahan, T. | +6

9

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial

enthalten in: American journal of hypertension | 2008

von Kurland, L. | Hallberg, P. | Melhus, H. | +5

10

Myocardial fibrosis and diastolic dysfunction in patients with hypertension : results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

enthalten in: Journal of hypertension | 2007

von Müller-Brunotte, R. | Kahan, T. | López, B. | +4

CommentIn: J Hypertens. 2008 Jul;26(7):1497; author reply 1497-9. - PMID 18551029